Abstract 6373: Development of a lipid nanoparticle formulation of the bifunctional PARP and HDAC inhibitor kt-3283.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Vancouver Prostate Centre, University of British Columbia
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7148878903
Cites:
Cited by:
Related to:
